Glen Eagle Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $615K | Buy |
1,749
+37
| +2% | +$13.2K | 0.09% | 155 |
|
|
2025
Q4 | $560K | Buy |
1,712
+13
| +0.8% | +$4.12K | 0.08% | 164 |
|
|
2025
Q3 | $479K | Sell |
1,699
-135
| -7% | -$39.2K | 0.07% | 179 |
|
|
2025
Q2 | $512K | Sell |
1,834
-26
| -1% | -$7.37K | 0.08% | 152 |
|
|
2025
Q1 | $580K | Buy |
1,860
+1
| +0.1% | +$295 | 0.1% | 133 |
|
|
2024
Q4 | $485K | Buy |
1,859
+1
| +0.1% | +$297 | 0.08% | 146 |
|
|
2024
Q3 | $599K | Sell |
1,858
-98
| -5% | -$32.1K | 0.1% | 134 |
|
|
2024
Q2 | $611K | Buy |
1,956
+105
| +6% | +$30.8K | 0.11% | 122 |
|
|
2024
Q1 | $526K | Buy |
1,851
+1
| +0.1% | +$293 | 0.1% | 141 |
|
|
2023
Q4 | $533K | Sell |
1,850
-127
| -6% | -$34.6K | 0.11% | 134 |
|
|
2023
Q3 | $531K | Sell |
1,977
-49
| -2% | -$12.2K | 0.12% | 130 |
|
|
2023
Q2 | $450K | Buy |
2,026
+4
| +0.2% | +$928 | 0.1% | 148 |
|
|
2023
Q1 | $489K | Buy |
2,022
+7
| +0.3% | +$1.72K | 0.12% | 132 |
|
|
2022
Q4 | $529K | Buy |
2,015
+66
| +3% | +$17.7K | 0.14% | 123 |
|
|
2022
Q3 | $439K | Sell |
1,949
-4
| -0.2% | -$970 | 0.13% | 138 |
|
|
2022
Q2 | $475K | Sell |
1,953
-7
| -0.4% | -$1.72K | 0.13% | 139 |
|
|
2022
Q1 | $474K | Sell |
1,960
-194
| -9% | -$44.6K | 0.12% | 148 |
|
|
2021
Q4 | $485K | Sell |
2,154
-446
| -17% | -$94.1K | 0.13% | 147 |
|
|
2021
Q3 | $553K | Sell |
2,600
-47
| -2% | -$10.8K | 0.16% | 130 |
|
|
2021
Q2 | $645K | Sell |
2,647
-54
| -2% | -$13.3K | 0.2% | 108 |
|
|
2021
Q1 | $672K | Buy |
2,701
+19
| +0.7% | +$4.53K | 0.23% | 98 |
|
|
2020
Q4 | $617K | Sell |
2,682
-80
| -3% | -$18.4K | 0.24% | 87 |
|
|
2020
Q3 | $702K | Sell |
2,762
-24
| -0.9% | -$5.95K | 0.31% | 72 |
|
|
2020
Q2 | $657K | Buy |
2,786
+8
| +0.3% | +$1.82K | 0.34% | 66 |
|
|
2020
Q1 | $563K | Sell |
2,778
-79
| -3% | -$17.3K | 0.4% | 59 |
|
|
2019
Q4 | $689K | Sell |
2,857
-30
| -1% | -$6.61K | 0.37% | 64 |
|
|
2019
Q3 | $559K | Hold |
2,887
| – | – | 0.37% | 65 |
|
|
2019
Q2 | $532K | Buy |
2,887
+41
| +1% | +$7.34K | 0.36% | 68 |
|
|
2019
Q1 | $541K | Buy |
2,846
+63
| +2% | +$12K | 0.39% | 57 |
|
|
2018
Q4 | $542K | Buy |
2,783
+50
| +2% | +$9.76K | 0.46% | 54 |
|
|
2018
Q3 | $566K | Buy |
2,733
+8
| +0.3% | +$1.58K | 0.4% | 60 |
|
|
2018
Q2 | $503K | Buy |
2,725
+25
| +0.9% | +$4.42K | 0.39% | 62 |
|
|
2018
Q1 | $460K | Buy |
2,700
+2,220
| +463% | +$408K | 0.38% | 63 |
|
|
2017
Q4 | $83.5K | Sell |
480
-2,156
| -82% | -$382K | 0.07% | 210 |
|
|
2017
Q3 | $491K | Buy |
2,636
+2,236
| +559% | +$396K | 0.46% | 51 |
|
|
2017
Q2 | $68.9K | Buy |
400
+19
| +5% | +$3.09K | 0.06% | 195 |
|
|
2017
Q1 | $62.5K | Buy |
381
+46
| +14% | +$7.64K | 0.05% | 187 |
|
|
2016
Q4 | $49K | Buy |
+335
| New | +$50.4K | 0.04% | 198 |
|
Other funds holding AMGN
VCM
VPM
Glen Eagle Advisors's AMGN Position: Q1 2026 in Review
Glen Eagle Advisors increased its Amgen (AMGN) stake by 2.2% in Q1 2026, buying an estimated $13.2K and bringing the position to 1,749 shares worth $615K. The position accounts for 0.09% of the portfolio, ranked #155.
Glen Eagle Advisors first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. The position peaked at $702K in Q3 2020. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Glen Eagle Advisors held 1,749 shares of Amgen worth $615K as of Q1 2026.
- Glen Eagle Advisors bought 37 Amgen shares in Q1 2026, an estimated $13.2K.
- Amgen made up 0.09% of Glen Eagle Advisors's portfolio in Q1 2026, its #155 holding.
- Glen Eagle Advisors first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
- Glen Eagle Advisors's Amgen position peaked at $702K in Q3 2020.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.